Evoq Remedies Share Price | Evoq Remedies Stock Screener
EVOQ
Trading & Distributors
Track Evoq Remedies share price live with TickJournal's free stock screener.
Analyse EVOQ price movement history and track historical price performance.
Use the Evoq Remedies stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Evoq Remedies Market Cap
₹6.30 Cr.
EVOQ P/E Ratio (TTM)
-
Evoq Remedies P/B Ratio
0.14
EPS (TTM)
₹-0.10
Dividend Yield
-
Debt to Equity
0.06
EVOQ 52 Week High
-
Evoq Remedies 52 Week Low
-
Operating Margin
-
Profit Margin
-
EVOQ Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹50.00
Total Equity
₹45.00
Evoq Remedies Share Price Chart
Screen Evoq Remedies share price with an interactive chart. Analyse EVOQ price trends and volatility across different timeframes.
Evoq Remedies Company Profile - Fundamental Screener
Screen Evoq Remedies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for EVOQ shares.
Sector
Commercial Services
Industry
Trading & Distributors
Sub-Sector
Trading & Distributors
Segment
E
ISIN
INE0JVD01011
Evoq Remedies Balance Sheet Screener
Screen EVOQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 50 | 37 | 35 | 33 | 8 | 6 | 2 |
| Current Assets | 50 | 37 | 35 | 33 | 8 | 6 | 2 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 45 | 25 | 25 | 23 | 1 | 0 | 0 |
| Share Capital | 25 | 14 | 14 | 14 | 0 | 0 | 0 |
| Reserves & Surplus | 20 | 12 | 11 | 10 | 1 | 0 | 0 |
Evoq Remedies Income Statement Screener - Profit & Revenue Analysis
Screen Evoq Remedies income statement and profit fundamentals.
Analyze EVOQ quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Evoq Remedies share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 26 | 14 | 6 | 26 | 17 | 10 | 9 | 3 |
| Expenses | 0 | 27 | 14 | 6 | 24 | 15 | 9 | 9 | 3 |
| EBITDA | 0 | -1 | 0 | 1 | 2 | 2 | 1 | 0 | 0 |
| Operating Profit % | 0.00% | -6.00% | -19.00% | -40.00% | -18.00% | 9.00% | 10.00% | 0.00% | 1.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 1 | 2 | 2 | 1 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 1 | 2 | 1 | 1 | 0 | 0 |
| EPS | 0.00 | -0.10 | 0.04 | 0.33 | 1.19 | 0.70 | 715.00 | 0.00 | 0.16 |
Evoq Remedies Cash Flow Screener - Liquidity Fundamentals
Screen EVOQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | -15 | 5 | -4 | -26 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 15 | -5 | 1 | 30 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | -3 | 3 | 0 | 0 | 0 |
Evoq Remedies Shareholding Pattern Screener
See Evoq Remedies shareholding pattern with promoter, FII, and DII holdings.
Check Evoq Remedies promoter holding and ownership changes for EVOQ on TickJournal.
| Item | 2026-Mar | 2025-Sept | 2025-Mar | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Sept | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.02% | 11.21% | 11.21% | 11.21% | 11.21% | 20.53% | 73.53% | 73.53% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 94.57% | 83.89% | 84.74% | 85.75% | 85.57% | 73.38% | 24.91% | 25.21% |
| Other Holding | 5.41% | 4.90% | 4.05% | 3.04% | 3.21% | 6.09% | 1.56% | 1.26% |
| Shareholder Count | 1,655 | 1,679 | 1,723 | 1,577 | 1,588 | 1,672 | 727 | 707 |
Evoq Remedies Share Dividend Screener - Share Yield Analysis
Check Evoq Remedies dividend history with payout and yield data.
View Evoq Remedies dividend details including ex-dates and amounts for EVOQ stock.
Evoq Remedies Stock Index Membership
See which indices include Evoq Remedies stock.
Check EVOQ index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Evoq Remedies Market Events Screener - Corporate Actions
Get Evoq Remedies corporate actions including splits, bonuses, and buybacks.
Check Evoq Remedies stock events that may affect EVOQ share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -3.40% | ||
| Annual General Meeting | NA | 7.43% | ||
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | -7.74% |
| 2025-10-10 | 2025-10-10 | Quarterly Result Announcement | NA | 14.87% |
| 2025-06-03 | 2025-06-03 | Extraordinary General Meeting | NA | 22.05% |
| 2025-04-10 | 2025-04-10 | Quarterly Result Announcement | NA | 9.77% |
| 2025-03-03 | 2025-03-03 | Quarterly Result Announcement | NA | 0.00% |
| 2024-02-28 | 2024-02-28 | Extraordinary General Meeting | NA | -1.84% |
| 2021-07-28 | 2021-07-28 | Change Of Name | NA | - |
Evoq Remedies Competitors Screener - Peer Comparison
Screen EVOQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Redington | 21,591 | 16.78 | 119,162 | 19.69% | 1,158 | 65.49 |
| MMTC | 10,208 | 25.85 | 1 | -99.46% | 550 | 48.25 |
| MSTC | 4,994 | 22.25 | 370 | -4.60% | 221 | 72.23 |
| Elitecon International | 4,268 | 12.96 | 551 | 55040.00% | 70 | 30.30 |
| Ravindra Energy | 3,282 | 40.02 | 543 | 107.17% | 84 | 66.72 |
| BN Agrochem | 2,915 | 81.21 | 873 | 137.82% | 17 | 53.80 |
| Vintage Coffee & Beverages | 2,256 | 30.23 | 553 | 76.98% | 72 | 55.67 |
| TCC Concept | 1,530 | 23.29 | 179 | 100.21% | 31 | 27.20 |
| Creative Newtech | 1,097 | 15.74 | 2,700 | 49.86% | 70 | 60.87 |
| The Yamuna Syndicate | 830 | 15.99 | 69 | 2.03% | 52 | 41.44 |
Evoq Remedies Company Announcements - News Screener
Screen EVOQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-06-11 | Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal | - |
| 2026-06-10 | Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal | - |
| 2026-05-30 | Integrated Filing (Finance) For The Half Year And Year Ended On 31St March 2026 | - |
| 2026-05-30 | Appointment Of M/S. Jay Pandya & Associates (FRN: S2024GJ963300) Company Secretaries Ahmedabad As Secretarial Auditor Of The Company For The Financial Year 2025-26. | - |
| 2026-05-30 | Submission Of Audited Financial Results For The Half Year And Year Ended On 31St March 2026 Along With AuditorS Report. | - |
| 2026-05-30 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday 30Th May 2026 And Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 | - |
| 2026-05-27 | Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 27Th May 2026 To 30Th May 2026 | - |
| 2026-05-11 | Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 14Th May 2026 To 27Th May 2026 | - |
| 2026-05-07 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 14Th May 2026 | - |
| 2026-04-30 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-10-24 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-10-23 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-10-23 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-10-10 | Integrated Filling (Finance) | - |
| 2025-10-10 | Financial Result For Half Year Ended On 30Th September 2025 | - |
| 2025-10-10 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |